Left ventricular structure in different types of chronic pressure overload

European Heart Journal, Supplement

Volumn 10, Issue E, 2008, Pages

  Gerdts, Eva ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Aortic stenosis; Hypertension; Left ventricular geometry; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADVERSE OUTCOME; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL;

EID: 69749102872     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sun015     Document Type: Article

References (18)

1. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
2. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550-1558.
3. Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Design and baseline characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. Am J Cardiol 2007;99:970-973.
4. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463.
5. Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, Dahlöf B, Devereux RB. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. Hypertension 2002;39:739-743.
6. Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebø AB, Gerdts E. Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS substudy). Am J Cardiol 2008;101:510-515.
7. Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, Devereux RB. Gender differences in left ventricular structure and function during antihypertensive treatment. The Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2008;51:1109-1114.
8. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A; Task Force on the Management of Valvular Health Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Eur Heart J 2007;28:230-268.
9. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 1996;28:751-756.
10. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352.
11. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Reboldi G, Porcellati C. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995;25:871-878.
12. Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Hypertension 1998;32:989-997.
13. Gerdts E, Cramariuc D, Wachtell K, De Simone G, Dahlof B, Devereux RB. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 2008; doi: 10.1093/ejechocard/jen155.
14. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004;292:2350-2356.
15. Antonini-Canterin F, Hunag G, Cervesato E, Faggiano P, Pavan D, Piazza R, Nicolosi GL. Symptomatic aortic stenosis. Does systemic hypertension play an additional role? Hypertension 2003;41:1268-1272.
16. Rieck AE, Cramariuc D, Staal EM, Rossebo A, Wachtell K, Gerdts E. Impact of concomitant hypertension on left ventricular structure in patients with aortic valve stenosis (Abstract 544). Eur J Echocardiogr. 2005;6(Suppl. 1):S76.
17. Chambers J, Takeda S, Rimington H, Lambert-Hammill M, Shetty C, Wierzbicki A. Determinants of left ventricular mass in aortic stenosis. J Heart Valve Dis 2004;13:873-880.
18. Gerdts E, Cramariuc D, Rieck AE, Staal EM, Wachtell K, Devereux RB. Left ventricular structure in different types of chronic pressure-overload (Abstract 3150). Circulation 2006;114(Suppl. II):666.